Perrigo Company plc, a top five global over-the-counter (OTC) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. From its beginnings in 1887 as a packager of generic home remedies, Perrigo, headquartered in Ireland, has grown to become the world's largest manufacturer of OTC products and supplier of infant formulas for the store brand market. The Company is also a leading provider of branded OTC products, generic extended topical prescription products and receives royalties from Multiple Sclerosis drug Tysabri®. Perrigo provides “Quality Affordable Healthcare Products®” across a wide variety of product categories and geographies primarily in North America, Europe, and Australia, as well as other key markets including Israel and China.

Company Growth (employees)
Type
Public
HQ
Dublin, IE
Founded
1887
Size (employees)
13,300 (est)
Perrigo was founded in 1887 and is headquartered in Dublin, IE

Perrigo Office Locations

Perrigo has offices in Dublin and Allegan
Dublin, IE (HQ)
2 Lower Grand Canal St
Allegan, US
515 Eastern Ave

Perrigo Financials and Metrics

Perrigo Financials

Perrigo's revenue was reported to be $1.2 b in Q1, 2018
USD

Revenue (Q1, 2018)

1.2 b

Gross profit (Q1, 2018)

464.4 m

Gross profit margin (Q1, 2018), %

39%

Net income (Q1, 2018)

71.6 m

EBIT (Q1, 2018)

128.5 m

Market capitalization (20-Oct-2017)

12.5 b

Closing share price (20-Oct-2017)

87.5

Cash (01-Apr-2017)

3.1 b
Perrigo's current market capitalization is $12.5 b.
USDFY, 2014FY, 2015FY, 2016

Revenue

4.1 b4.6 b1.3 b

Revenue growth, %

13%(71%)

Cost of goods sold

2.9 b

Gross profit

1.7 b
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

1.3 b1.4 b1.5 b1.4 b1.2 b

Cost of goods sold

795.9 m860.3 m913.8 m848.6 m729.6 m

Gross profit

548.8 m522.9 m567.2 m506.3 m464.4 m

Gross profit Margin, %

41%38%38%37%39%
USDFY, 2014FY, 2015FY, 2016

Cash

799.5 m785.6 m622.3 m

Accounts Receivable

935.1 m1.3 b

Inventories

631.6 m838.9 m795 m

Current Assets

2.6 b3.2 b2.8 b
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

609.4 m891.5 m3.6 b506.5 m588.9 m641.8 m362.7 m3.1 b

Accounts Receivable

869.4 m924.7 m

Inventories

693.5 m656.8 m641.8 m637 m888 m868.8 m894.6 m884.6 m800.2 m

Current Assets

2.3 b2.6 b5.4 b5.1 b2.9 b3 b3 b2.6 b5.1 b
USDFY, 2014FY, 2015FY, 2016

Net Income

(205.3 m)128 m42.5 m

Depreciation and Amortization

358.9 m548.8 m182.4 m

Accounts Receivable

(230 m)(82 m)52.5 m

Inventories

83 m10.7 m(29.6 m)
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

48.1 m96.3 m70.2 m(94.9 m)112.6 m(334.6 m)(140.3 m)(1.4 b)71.6 m

Depreciation and Amortization

175.4 m182.5 m369.3 m556.3 m109.4 m

Accounts Receivable

46.2 m23 m42.3 m113.6 m50.1 m

Inventories

(57 m)(14.8 m)(50.3 m)(29.9 m)500 k
Y, 2017

Financial Leverage

2.3 x
Show all financial metrics

Perrigo Market Value History

Perrigo Median Salaries

Source: 11 public H-1B filings from Perrigo

Traffic Overview of Perrigo

Perrigo Online and Social Media Presence

Perrigo News and Updates

Infant Formula Milk Powder Industry 2017 Global Market By Segment, Types, Regions, Applications And Forecast To 2022

Wiseguyreports.Com Adds “Infant Formula Milk Powder-Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

SK Capital to buy Perrigo API

SK Capital has agreed to acquire Perrigo API, an Israeli maker of generic active pharmaceutical ingredients and finished dose forms. No financial terms were disclosed. The deal is expected to close in the fourth quarter of this year. RBC Capital Markets LLC and Rothschild served as buyside advisers …

Small is lucrative for Wachtell, corporate America's legal defense force

NEW YORK (Reuters) - Every Tuesday, partners and associates at Wachtell, Lipton, Rosen & Katz gather for a communal lunch in the dining room of the law firm's Manhattan offices.

Floundering Perrigo's CEO Hendrickson to depart after rocky 13-month tenure

It’s been a tough 13-plus months for Perrigo since John Hendrickson stepped in for departing CEO Joseph Papa. And now, the company is getting another change at the top.

Perrigo Company Life and Culture

You may also be interested in